How to advance or delay the period with the contraceptive pill

Many people using hormonal contraception ask whether it is possible — and safe — to change the timing of their menstrual bleeding. Common reasons include travel, athletic competitions, special events, religious observances, or professional obligations. Combined hormonal contraceptives (those that contain both estrogen and progestin) provide reliable options to delay or schedule bleeding. Other methods (progestin-only pills, depot injection, intrauterine devices) have different effects on bleeding patterns and are less predictable when used specifically to time menses.

This article reviews the physiology behind withdrawal bleeding, explains practical, evidence-based ways to delay or advance bleeding with various contraceptive formulations (combined oral contraceptives, the transdermal patch, and the vaginal ring), describes likely side effects, and summarizes safety considerations and alternatives. Recommendations are framed for medical education; individual management should be discussed with a clinician. Sources used include professional guidelines and patient information from ACOG, NIH/MedlinePlus, Mayo Clinic, and Cleveland Clinic.

How combined hormonal contraception controls bleeding

Combined hormonal contraceptives (CHCs) — oral combined pills, the transdermal patch, and the vaginal ring — deliver estrogen and progestin. These hormones suppress the hypothalamic–pituitary–ovarian axis, preventing ovulation and stabilizing the endometrium (uterine lining). The regular “period” experienced by users of CHCs is usually a withdrawal bleed that occurs when the externally supplied hormones are stopped (for example, during the pill’s hormone-free or placebo days). This bleeding is different from a natural menstrual period driven by cyclical ovarian hormones; it is provoked by the sudden decrease in exogenous hormones.

Because withdrawal bleeding results from stopping hormones rather than a return of natural ovulation, the timing of that bleeding is under the user’s control to some extent: by continuing active hormones or by stopping them earlier, one can usually delay or advance bleeding (ACOG; Mayo Clinic; Cleveland Clinic).

(See: ACOG Practice Bulletin and patient FAQs; MedlinePlus — Birth control pills; Mayo Clinic — Skipping your period with birth control.)

General principles for altering bleeding timing

To delay bleeding: continue taking active hormone (active pills, keep ring/patch in place) and skip the hormone-free or placebo interval. This prevents the withdrawal drop in hormones that triggers bleeding.
To advance bleeding: interrupt active hormone by taking the placebo or removing the hormonal delivery device; withdrawal bleeding usually begins within 48–72 hours.
Safety and effectiveness: when used correctly, adjusting CHC regimens for short-term timing is generally effective and safe for most healthy users. However, skipping or altering hormone schedules can increase breakthrough spotting and requires attention to contraceptive effectiveness and contraindications (ACOG; Mayo Clinic).
Progestin-only methods and long-acting reversible contraception (LARC) have different effects and are less amenable to precise short-term timing.

Below we review specific methods and step-by-step guidance.

How to delay a period with combined oral contraceptive pills

Combined oral contraceptives commonly come in several regimens:

21/7: 21 days of active pills followed by 7 days of placebo (or no pills).
24/4 or 24/7: 24 days of active pills and 4 (or 7) days of placebo/inactive pills.
Extended-cycle packs (for example, 84/7): 84 days of active pills followed by 7 days of placebo, producing bleeding approximately every three months.
Continuous regimens: some products or clinical practices recommend continuous daily active pills, with no scheduled hormone-free interval.

Practical steps to delay bleeding with COCs

If you are on a 21/7 or 24/4 regimen and do not want a withdrawal bleed at the scheduled time, skip the hormone-free interval and begin the next pack of active pills immediately. For example, on a 21/7 pill: instead of taking the 7 inactive pills, start active pills from a new pack the day after finishing the 21 active pills.
If you are already taking placebo pills when you decide to delay bleeding, resume active pills as soon as you wish to prevent bleeding; bleeding may not be entirely prevented if you begin the active pills after bleeding has already started.
Extended-cycle packs are designed to limit scheduled bleeding to once every 3 months; many clinicians prescribe these when recurrent scheduling is desired (e.g., seasonal bleeding).
Continuous use (taking active pills without any placebo break) is an option for many users; it may cause more spotting in the first 2–3 months, with bleeding typically decreasing over time.

Clinical considerations and timing

There is no clear requirement to “prepare” several weeks in advance to delay bleeding. If you wish to avoid bleeding for an upcoming event, you may begin skipping the placebo interval immediately before the event. However, if you are concerned about breakthrough bleeding and want the most predictable suppression, using continuous or extended regimens for at least one cycle beforehand may improve likelihood of success.
If you skip the placebo interval, continue active pills uninterrupted. Do not skip more than the prescribed continuous active pills’ safe interval recommended by your clinician without guidance. If you inadvertently have a hormone-free interval longer than 7 days, contraceptive protection can be reduced and you may need backup contraception (condoms) for 7 days (CDC and ACOG guidance on missed pills).

(References: ACOG — Extended or Continuous Use of Combined Hormonal Contraceptives; Mayo Clinic — Birth control pill: Can I skip my period?; Cleveland Clinic — How to skip or delay your period.)

How to advance (bring on) bleeding with combined oral contraceptives

To bring on withdrawal bleeding earlier than expected:

Stop the active pills and take the placebo (or stop pills entirely) to induce a withdrawal bleed. Bleeding usually begins within 48–72 hours but timing varies.
Once bleeding has started, you can resume active pills (start a new pack) if you wish to return to regular contraception and alter the timing. If you resume active pills after a pill-free interval, you may need to use backup contraception for 7 days if you had a hormone-free interval long enough to allow ovulation risk; check specific guidance based on your pill formulation and any missed-pill instructions.

Clinical nuances and contraception protection

Bringing on bleeding by taking placebo early creates a hormone-free interval. If this interval is longer than recommended (generally >7 days for combined hormonal methods), ovulation may occur and contraceptive effectiveness can be reduced. If you plan to stop active pills to induce bleeding and then resume active pills, plan the sequence in consultation with your clinician to ensure contraceptive coverage.
If unprotected intercourse occurs during a prolonged hormone-free interval, consider emergency contraception per established guidelines (timing and eligibility apply).

(References: Mayo Clinic — Skipping your period; ACOG patient resources; CDC/NIH guidance on contraceptive continuation and missed pills.)

Using the vaginal ring or transdermal patch to delay or advance bleeding

Vaginal ring (e.g., etonogestrel/ethinyl estradiol ring)

Standard use: insert ring for 3 weeks, remove for 1 week to allow withdrawal bleeding.
To delay bleeding: leave the ring in place beyond 3 weeks and continue without the 7-day ring-free interval. Replace the ring at three-week intervals with a new ring when due (or follow the product-specific recommended continuous-use guidance).
To advance bleeding: remove the ring and replace it with a new ring after the desired bleeding interval; removal will usually trigger withdrawal bleeding within 48–72 hours.

Transdermal patch (combined patch)

Standard use: apply patch weekly for 3 weeks, then remove for 1 week.
To delay bleeding: continue applying a new patch each week without the patch-free week (replace weekly as usual). This maintains hormone levels and prevents withdrawal bleeding.
To advance bleeding: remove patches and begin the patch-free interval or stop applying patches; withdrawal bleeding usually begins within a few days.

General notes for ring/patch

Continuous use of ring/patch to delay bleeding follows the same physiologic principle as continuous pills: prevent the hormone-free interval that triggers bleeding.
When planning to change schedules with ring or patch, verify the manufacturer’s instructions and discuss with a clinician about timing and contraceptive protection.

(References: ACOG; Mayo Clinic — Birth control ring; Cleveland Clinic — Transdermal patch guidelines.)

What about progestin-only pills, injections, and intrauterine systems?

Progestin-only pills (the “mini-pill”)

Progestin-only pills do not consistently suppress ovulation in all users and have a different mechanism. They are not reliable for scheduling or timing bleeding. Attempts to time menses by stopping or starting progestin-only pills can produce unpredictable bleeding patterns. If precise timing is important, combined methods are preferable.

Depot medroxyprogesterone acetate (DMPA) injection

The DMPA injection commonly leads to irregular bleeding in the first months and a progressive decrease in bleeding over time, with many users becoming amenorrheic. DMPA is not a practical short-term tool to “advance” or “delay” a single upcoming bleeding episode because its effects on bleeding are not quickly reversible or precisely timed.

Levonorgestrel-releasing intrauterine system (LNG-IUS)

The LNG-IUS often reduces menstrual bleeding substantially and may lead to amenorrhea over months. It is not a method typically used to time a single bleeding episode in the short term, though it is a long-term option for reducing or eliminating menses.

(Reference: NIH/MedlinePlus; ACOG — LARC resources.)

Expected side effects and bleeding patterns when manipulating regimens

Breakthrough bleeding and spotting: The most common side effect of extended or continuous CHC use is irregular bleeding or spotting, especially during the first 2–3 months. For many users this resolves with continued use. Persistent bothersome bleeding may prompt a change in product or a short hormone-free interval under clinician direction (ACOG; Mayo Clinic).
Nausea, breast tenderness, headaches, mood changes: These systemic side effects can occur with continued or increased exposure to hormonal contraception.
Venous thromboembolism (VTE) risk: Combined estrogen-containing methods carry a small increased risk of VTE compared with non-use. The absolute risk remains low for most healthy non-smoking users under age 35. Risk factors (age >35 and tobacco use, personal or family history of thromboembolism, certain clotting disorders, migraine with aura, uncontrolled hypertension) may make CHCs unsafe; these conditions are contraindications to estrogen-containing contraception (ACOG; CDC Medical Eligibility Criteria).
Long-term fertility: For most CHC users, fertility returns promptly after discontinuation. The exception is the depot medroxyprogesterone injection, which may delay return of ovulation for several months after cessation.

(References: ACOG Practice Bulletins; CDC/WHO Medical Eligibility Criteria summaries; Mayo Clinic — Side effects of birth control pills; NIH MedlinePlus.)

Safety, contraindications, and when to consult a clinician

Before altering a contraceptive regimen with the intent to delay or advance bleeding:

Review contraindications to estrogen (smoking age >35, history of blood clots, certain migraine types, uncontrolled high blood pressure, some cardiovascular conditions, certain liver conditions). If any contraindications are present, the combined method is not appropriate (ACOG; CDC).
If you have a history of irregular bleeding on your current method, manipulation of the schedule may increase unpredictable bleeding. Discuss alternatives with your clinician.
If you have experienced very heavy bleeding, severe abdominal pain, or other red flags, seek medical evaluation before changing contraception.
If you are taking medications that interact with hormonal contraception (enzyme-inducing drugs such as some anticonvulsants or antibiotics like rifampin; certain herbal products such as St. John’s wort), those interactions may reduce hormone levels and reduce the effectiveness of any timing strategy. Clinician input is recommended.
If you inadvertently have a hormone-free interval of more than 7 days on CHCs or miss multiple active pills, use condoms or abstain until you have taken active pills for 7 consecutive days. If unprotected intercourse occurred during the period of missed contraceptive protection, consider emergency contraception and consult a clinician.

(References: ACOG; CDC — U.S. Medical Eligibility Criteria; NIH/MedlinePlus.)

Practical examples and timelines

Example A — Delay bleeding for a 7-day trip using a 21/7 pill:

Usual schedule: Days 1–21 active pills; Days 22–28 placebo — withdrawal bleeding occurs during days 22–28.
To avoid bleeding during the week of travel: On day 22, instead of taking placebo, begin a new pack of active pills and continue active pills daily. You will not have a scheduled withdrawal bleed during the trip. Continue active pills until you want a withdrawal bleed, then take a 7-day placebo interval or stop active pills to trigger bleeding.

Example B — Bring bleeding forward to avoid a future date:

If you want a withdrawal bleed earlier (e.g., now rather than in one week): stop active pills and take placebo (or no pills). Withdrawal bleeding usually begins within 48–72 hours. After bleeding finishes, resume active pills by starting a new pack (consider using backup protection if your pill-free interval exceeded 7 days or if instructed by your clinician).

Example C — Using the ring to delay bleeding for an event:

Standard ring schedule: 3 weeks in, 1 week out.
To delay: leave the ring inserted beyond three weeks and replace with a new ring on or before 4 weeks to maintain continuous hormone exposure. Keep the ring in place through the duration of the event. Expect more irregular bleeding or spotting initially.

Note: These examples are for typical combined formulations. Always check the specific pill pack’s instructions and discuss with your clinician, particularly if you have missed pills recently or are changing methods.

(References: Mayo Clinic; Cleveland Clinic; ACOG patient FAQs.)

Will manipulating the schedule harm fertility or health?

Short-term manipulation of CHCs to delay or advance withdrawal bleeding is not associated with long-term harm to fertility. Fertility normally returns after discontinuation of combined contraceptives.
Continuous or extended use of CHCs has been studied and is considered safe for many users; it does not cause long-term infertility and is an accepted practice (ACOG).
Frequent or repeated unsupervised alterations in contraceptive schedules without attention to missed-pill guidance may increase the risk of unintended pregnancy if contraceptive protection is reduced. Always adhere to missed-pill/back-up contraception recommendations when changing schedules.

(References: ACOG; NIH/MedlinePlus.)

Alternatives if CHCs are not appropriate

If combined hormonal contraception is contraindicated or unwanted, other options to manage bleeding include:

Levonorgestrel IUD (LNG-IUS): Gradually reduces menstrual bleeding; many users experience markedly lighter periods or amenorrhea after several months. Not useful for short-term timing but effective for long-term reduction of bleeding.
Progestin-only methods: unpredictable for scheduling and not reliable for timing an upcoming period.
Non-hormonal options: no effective way to schedule or reliably delay bleeding non-hormonally for a single cycle. Symptomatic management (analgesics, NSAIDs) may be used for discomfort during bleeding.
Discuss with your clinician which method best matches your bleeding goals, medical history, and risk profile.

(References: ACOG LARC resources; Mayo Clinic.)

Frequently asked questions (brief)

Will skipping the placebo week make contraceptive pills less safe?
For most healthy users, skipping the placebo week by continuing active pills is safe and an accepted practice. The estrogen-associated risks remain related to overall CHC use; consult your clinician if you have risk factors for thromboembolism or other contraindications (ACOG; CDC).

Is it safe to use multiple packs back-to-back for months?
Many clinicians prescribe extended or continuous regimens. It is common practice to use active pills continuously for months; doing so may increase short-term irregular bleeding but is generally safe in appropriate candidates. Follow-up with your clinician is recommended if bleeding is persistent or heavy.

Can I manipulate the schedule if I am on a progestin-only pill?
Progestin-only pills do not reliably permit scheduling of bleeding. Stopping or starting them to time menses is unpredictable.

Does manipulating my period increase cancer risk?
Current evidence does not indicate that short-term manipulation of scheduled withdrawal bleeding with CHCs increases cancer risk. Combined hormonal contraception has complex associations with cancer risks but is overall considered safe when used according to guidelines; discuss personal risks with your clinician (ACOG; NIH).

(References: NIH/MedlinePlus; ACOG; Mayo Clinic.)

Summary and clinical recommendations

Combined hormonal contraceptives (oral pills, ring, patch) permit reliable delay or scheduling of withdrawal bleeding by avoiding the hormone-free interval (to delay) or introducing one early (to advance).
To delay: continue active pills or keep the ring/patch in place without the usual off week. This is commonly done and supported by ACOG and major clinical bodies.
To advance: stop active hormones (take placebo or remove device) to induce withdrawal bleeding, then resume active contraception if continued protection is desired; plan carefully to avoid prolonged hormone-free intervals that can reduce contraceptive efficacy.
Expect some breakthrough bleeding when changing schedules; this often settles with continued use.
Evaluate contraindications and drug interactions before altering estrogen-containing regimens. If in doubt, consult a clinician to choose the safest approach.
If you rely on CHCs for contraception and you change your schedule, follow missed-pill and backup-protection guidance to maintain contraceptive efficacy.

For personalized advice and medical eligibility assessment, consult your healthcare provider. Reliable patient resources include the American College of Obstetricians and Gynecologists (ACOG), the National Institutes of Health/MedlinePlus, the Mayo Clinic, and the Cleveland Clinic.

(Selected references: ACOG — patient FAQs and practice guidance on extended/continuous CHC use; NIH/MedlinePlus — Birth control pills; Mayo Clinic — Skipping your period with birth control; Cleveland Clinic — How to skip or delay your period.)